Recent advances in immunotherapy research have revealed crucial roles for new immune cells in combating cancer, leading to ...

PsiOxus Therapeutics aims to be the world’s leading cancer gene ... stimulator of interferon genes (STING) signaling pathway and acts to stimulate macrophage, natural killer cell and dendritic ...

Prostate cancer and other cancers characterized by “cold” tumors could become more responsive to checkpoint blockade if UBA1 is inhibited.

In recent decades, immunotherapy has transformed cancer treatment, offering effective options for diseases once considered ...

Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers, with a survival rate of just 11%. A primary culprit ...

1 Two phase III studies—Avastin for Renal Cell Cancer (AVOREN) 7 and Cancer and Leukemia Group B (CALGB) 90206 8 indicated significant improvements in PFS for bevacizumab plus interferon-α ...

Interferons are signaling molecules that are released by cells in response to viral infections ... Read the study: “Chronic Interferon Stimulated Gene Transcription Promotes Oncogene Induced Breast ...

A novel combination resulted in tumor regression during preclinical lab testing by scientists at the nonprofit Wistar ...

In an interview, Vincent Law, of Moffitt Cancer Center, discussed a new study that offers hope for patients with melanoma ...

The study reveals IL-15's role in enhancing GPC3 CAR T cell therapy, improving tumor targeting and T cell survival in ...

STC-15, an investigational RNA methyltransferase inhibitor, has shown promising clinical activity and an encouraging safety ...